Blogs
BREAKING NEWS
LATEST NEWS
Connected Data, Interoperability Enable Greater Compliance and Beyond
Regulatory teams serve as the common thread of pharmaceutical research and development, connecting each domain on a drug’s journey to approval. Theirs is the only function that plays a role in every stage of bringing a drug to market, from initial research through...
Harnessing Medical Affairs’ Strategic Potential
When saddled with legacy medical information systems, Medical Affairs teams are forced to behave like detectives, hunting down information across disjointed systems and ferreting insights out of vast databases just to satisfy the inquiry of a single customer. Outdated...
Vaccine Safety in the Public Eye: How COVID-19 Brought Pharmacovigilance Center-Stage
The coronavirus pandemic ushered in a new era of public scrutiny for the pharmaceutical industry. The general population was traditionally most invested in novel medicines in clinical trials – news reports and medical journal articles about new, promising drugs would...
The Path to Breakthrough
Learn why Breakthrough is more than just an event but a summit for thought leaders in health and life sciences to discuss today and the future.
The Digital Mindset in Drug Safety and Moving the Needle for your Organization
Digital Transformation is Accelerating Digital transformation, automation and analytics were top of mind when ArisGlobal recently hosted a thought leadership roundtable over challenges and topical issues within the drug safety space. Leading Safety executive leaders...
5 Key Takeaways From the 2021 DIA Medical Affairs and Scientific Communications Forum
The DIA Medical Affairs and Scientific Communications (MASC) Forum is created for medical affairs professionals by the best in their field. The annual forum is designed to provide information and guidance on all things affecting medical affairs. This includes...
PRODUCTS NEWS
Think Global, Watch Local: The DIA 2020 Annual Meeting Is Now Virtual, and ArisGlobal Is All In
The DIA 2020 Annual Meeting Is Now Virtual. ArisGlobal will be front and center with presentations covering both Safety and Clinical perspectives in Life Sciences process management.
The Clinical Domain is Evolving. Make Sure your CTMS is Evolving with It.
The Evolving Role of CTMS in Risk Management takes a broad look at the challenges facing clinical trial management, how the clinical domain is changing, and how the industry can better respond.
ArisGlobal’s LifeSphere CTMS10 Brings Complete Control and Full Visibility to Clinical Trials
A versatile Clinical Trial Management Solution, LifeSphere® CTMS10 contains great functionality and five key benefits, addressing a variety of challenges in the clinical product lifecycle.
Letter From Our CEO: Nordic Capital Acquires ArisGlobal, Fuels Growth
It is with great excitement that we announce that Nordic Capital has entered into a definitive agreement to acquire ArisGlobal. Over these 32 years, ArisGlobal has built a sustainable and growing business that thrives on its partnerships with many life sciences companies and regulatory agencies. These customer relationships, some lasting decades, have allowed ArisGlobal to become a leading healthcare technology company with over 1200 employees across an expansive global footprint.
ArisGlobal Is Going “All-In” on Amazon AWS. Here Is What It Means to Our Customers.
ArisGlobal, part of the more cautious and highly regulated life science go “all-in on AWS” by moving the entire cloud infrastructure to the AWS platform. This move benefits both ArisGlobal and to our customers.
Creating a Unified Clinical and Regulatory Data Management Strategy
Examining the challenges involved, benefits to be gained and requirements of unified regulatory and clinical business processes, as well as recommendations for taking the next steps forward.
PRESS RELEASES
LifeSphere Medical Affairs Product Leader to Present at DIA MASC
MIAMI, FL - March 18, 2022 - ArisGlobal®, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today announces its virtual participation in DIA’s Medical Affairs and...
ArisGlobal’s LifeSphere Safety Solidifies Market Leading Position in Pharmacovigilance with Over 300 Customers and More Than 7 million Safety Cases Processed Annually
ArisGlobal’s signature R&D Safety suite continues to record substantial global gains within the life sciences industry, including 30 of the Top 50 global pharma organizations. MIAMI, FL – ArisGlobal®, the leading provider of life sciences software that automates...
ArisGlobal Recognized in 2021 Gartner® Hype Cycle™
Leading automated drug development technology platform LifeSphere recognized for outstanding Life Science Research and Development capabilities MIAMI (March 9, 2022) — ArisGlobal, the leading provider of life sciences software that automates core drug development with...
Top 5 Pharma Looks to LifeSphere IDMP for Regulatory Readiness
ArisGlobal’s industry-leading regulatory software chosen by top pharmaceutical company for IDMP preparation and global readiness MIAMI, Feb 15 - ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end...
ArisGlobal Presents IDMP for Global Regulatory Affairs at DIA RSIDM
LifeSphere product leaders share insight into how an effective IDMP strategy can support various business functions MIAMI, FL and VIRTUAL, February 14, 2021 - ArisGlobal, the leading provider of life sciences software that automates core drug development functions...
Cloud Software Veteran Mike Gordon Succeeds Sankesh Abbhi as CEO of ArisGlobal
Serving as ArisGlobal’s Board Chairman since 2020, Gordon will assume the role of Chairman and CEO. Sankesh Abbhi remains actively involved as non-executive Board Director. MIAMI, FL – 2/4/2022 – ArisGlobal, the leading provider of life sciences software that...